Cited by 8Medicinal Plants and NeuroprotectionAlzheimer's disease research and treatmentsCholinesterase and Neurodegenerative Diseases

Treatment of Alzheimer’s disease by natural products

Open access
CHOUGLE, Sana, KUMAR, Dinesh, KHAN, Andleeb, ZEHRA, Sadaf, ALİ, Ahmad·2021·Journal of Experimental and Clinical Medicine

Abstract

Alzheimer’s disease is a neurological disorder that progressively affects the brain cells. It is sometimes accompanied with dementia and commonly seen in elderly people. It ultimately leads to impaired cognitive functions and loss of memory. Widely used drugs such as donepezil and galantamine successfully abate mild to moderate symptoms of the disease though they have profound side effects. Natural products have been a source of medicine for over thousands of years. Plant secondary metabolites such as alkaloids, flavonoids, terpenoids, etc. are major sources of such medicines. In recent times, the use of natural products to treat various diseases has gained a lot of popularity. Extensive research is being undertaken to identify and isolate various natural products that can be used to not only reduce the disease symptoms but also as a permanent cure. The review article aims to summarize the effects of various natural products and their neuroprotective mechanisms that can be helpful to cure Alzheimer’s disease.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.52142/omujecm.38.4.42

Cites

48 of 48 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 12

  1. Ali A. Herbs that heal: the philanthropic behavior of nature. Ann Phytomed. 2020; 9(1), 7-17.
  2. Ijaz H, Tulain UR, Qureshi J, Danish Z, Musayab S, Akhtar MF, et al. (prophetic medicine): a review. Pak J Pharm Sci. 2017; 30, 229-234.
  3. Chen CL, Tsai WH, Chen CJ, Pan TM. Centella asiatica extract protects against amyloid β1-40-induced neurotoxicity in neuronal cells by activating the antioxidative defence system. J Trad Complement Med. 2015; 6, 362-369.
  4. Taguchi R, Hatayama K, Takahashi T, Hayashi T, Sato Y, Sato D, et al Structure-activity relations of rosmarinic acid derivatives for the amyloid β aggregation inhibition and antioxidant properties. Eur J Med Chem. 2017; 138, 1066-1075.
  5. Senol FS, Slusarczyk S, Matkowski A, Perez-Garrido A, Giron- Rodriguez F, Ceron-Carrasco JP, et al. Selective in vitro and in silico butyrylcholinesterase inhibitory activity of diterpenes and rosmarinic acid isolated from Perovskia atriplicifolia Benth and Salvia glutinosa L Phytochemistry. 2017; 133, 33-44.
  6. Khodagholi F, Eftekharzadeh B, Maghsoudi N, Rezaei PF. Chitosan prevents oxidative stress-induced amyloid beta formation and cytotoxicity in NT2 neurons: involvement of transcription factors Nrf2 and NF-kappaB. Mol Cell Biochem. 2010; 337, 39-51.
  7. Grzanna R, Phan P, Polotsky A, Lindmark L, Frondoza CG. Ginger extract inhibits beta-amyloid peptide-induced cytokine and chemokine expression in cultured THP-1 monocytes. J Altern Complement Med. 2004; 10, 1009-1013.
  8. Sahardi NFNM, Makpol S. Ginger (Zingiber officinale Roscoe) in the prevention of ageing and degenerative diseases: review of current evidence. Evid Based Complement Alternat Med. 2019, 5054395.
  9. Akhondzadeh S, Sabet MS, Harirchian MH, Togha M, Cheraghmakani H, Razeghi S, et al. Saffron in the treatment of patients with mild to moderate Alzheimer's disease: a 16-week, randomized and placebo-controlled trial. J Clin Pharm Ther. 2010; 35, 581-588.
  10. Leone S, Recinella L, Chiavaroli A, Orlando G, Ferrante C, Leporini L, et al. Phytotherapic use of Crocus sativus L. (Saffron) and its potential applications: a brief review. Phytother Res. 2017; 32, 2364-2375.
  11. Kaur N, Sarkar B, Gill I, Kaur S, Mittal S, Dhiman M, et al. Indian herbs and their therapeutical potential against Alzheimer's disease and other neurological disorders. In Neuroprotective Effects of Phytochemicals in Neurological Disorders, First eds. John Wiley and Sons Inc. 2017; 79-112.
  12. Rather MA, Thenmohzi AJ, Manivasagam T, Bharathi MD, Essa M, Guillemin GJ. Neuroprotective role of Asiatic acid in aluminium chloride induced rat model of Alzheimer's disease. Front Biosci. 2018; 10, 262-275.

Cited by

Sorted by citations

Authors
CHOUGLE, S., KUMAR, D., KHAN, A., ZEHRA, S., & ALİ, A.
Affiliations
  • University of Mumbai (IN)
  • Jazan University (SA)
  • University of Windsor (CA)
Venue
Journal of Experimental and Clinical Medicine
Published
2021-08-30
Volume
38
Issue
4
Pages
634-644
ISSN
  • 1309-4483 (ISSN-L)
  • 1309-5129
OpenAlex
W3198975966
Cited by
8
References
48
Citations by year
2025: 1 · 2023: 3 · 2022: 4
FWCI
1.97
Type
journal article
Language
en
Open access
Locations
  • Journal of Experimental and Clinical Medicine (publishedVersion)
  • DergiPark (Istanbul University) (submittedVersion, cc-by-nc)
Funders
Research Society for the Study of Diabetes in India (2017/342, RSSDI/HQ/Grants/2017/342)
Topics
  • Health Sciences › Medicine › Complementary and alternative medicine › Medicinal Plants and Neuroprotection
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
  • Health Sciences › Medicine › Pharmacology › Cholinesterase and Neurodegenerative Diseases
Keywords
Alzheimer's disease, natural products, plant secondary metabolites, neuroprotection, alkaloids, flavonoids, terpenoids, cognitive impairment, memory loss, dementia, donepezil, galantamine

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review